ArticleJournal of translational medicine2022

A humanized 4-1BB-targeting agonistic antibody exerts potent antitumor activity in colorectal cancer without systemic toxicity.

Lian-Sheng Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.